Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by JordanDeeon Dec 23, 2017 4:22pm

208 Views

Post# 27222436

News just out about issuing MORE shares...?

New Age Farm Issues Securities New Age Farm Issues Securities Vancouver, British Columbia (FSCwire) - New Age Farm Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (www.newagefarminc.com) (New Age Farm or the Company) announces that in has granted 3,900,000 stock options exercisable into Common shares of the Company at a price of $0.14 per Common share, expiring two years from date of grant, as part of its consultant compensation program. The issuance of the securities described in this news release is subject to acceptance by the Canadian Securities Exchange. All amounts quoted in this news release are in Canadian funds.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"